{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:39:30Z","timestamp":1773779970393,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01-NS038455"],"award-info":[{"award-number":["U01-NS038455"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014056","name":"Faculty of Science, Agriculture and Engineering, Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107162","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T18:21:51Z","timestamp":1592677311000},"page":"107162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Contraceptive vaginal ring reduces lamotrigine levels"],"prefix":"10.1016","volume":"111","author":[{"given":"Alexa","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheal P.","family":"Macken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungwha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth E.","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.yebeh.2020.107162_bb0005","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1001\/jama.2017.14485","article-title":"Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children","volume":"318","author":"Bromley","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2020.107162_bb0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2009.08.005","article-title":"Hormonal aspects of epilepsy","volume":"27","author":"Pennell","year":"2009","journal-title":"Neurol Clin"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107162_bb0015","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107162_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/ecp.10.3","article-title":"Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107162_bb0025","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107162_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-based lamotrigine clearance changes during pregnancy: clinical implication","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2020.107162_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107162_bb0040","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107162_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107162_bb0050","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1528-1167.2006.00558.x","article-title":"Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy","volume":"47","author":"Contin","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107162_bb0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/epi.13320","article-title":"Contraceptive practices of women with epilepsy: findings of the epilepsy birth control registry","volume":"57","author":"Herzog","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107162_bb0060","author":"Drugs.com. [Internet]"},{"key":"10.1016\/j.yebeh.2020.107162_bb0065","author":"Drugs.com. [Internet]"},{"key":"10.1016\/j.yebeh.2020.107162_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2020.107162_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmocokinetics of etonogestren and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2020.107162_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107162_bb0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107162_bb0090","author":"Drugs.com. [Internet]"},{"key":"10.1016\/j.yebeh.2020.107162_bb0095","first-page":"197","volume":"61","year":"2019","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.yebeh.2020.107162_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2005","journal-title":"Br J Clin Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:39:19Z","timestamp":1761503959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020303413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"alternative-id":["S1525505020303413"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107162","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraceptive vaginal ring reduces lamotrigine levels","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107162"}}